GRAS Notices
-
GRN No. 934
Algal oil (≥35% docosahexanoic acid (DHA)) derived from Schizochytrium sp. strain CABIO-A-2
Intended Use: | Intended for use as an ingredient, at up to 5.8 % (w/w) in food categories as listed in 21 CFR 184.1472(a)(3), and at up to 0.5% (w/w) of fatty acids as DHA in non-exempt infant formula for term infants. |
---|---|
Basis: | Scientific procedures |
Notifier: | CABIO Biotech (Wuhan) Co., Ltd. |
Notifier Address: |
Wuhan Pharmacy Park, Jiangxia Avenue Jiangxia Economic Development Zone Wuhan, Wuhan CHINA |
GRAS Notice (releasable information): | GRN 934 (2.0 MB) |
Date of closure: | Jul 20, 2021 |
FDA's Letter: | FDA has no questions (in PDF) (214 kB) |
-